Ex Parte HERRMANN et al - Page 2


                Appeal No. 2002-1630                                                  Page 2                  
                Application No. 09/175,713                                                                    

                   5.    A composition comprising an isolated polynucleotide encoding an                      
                         amino-terminal-modified chemokine, wherein the                                       
                         amino-terminal-modified chemokine comprises at least one methionine                  
                         at least one aminooxypentane residue or at least one GroHEK peptide                  
                         covalently attached to the amino terminus of the chemokine, and                      
                         wherein the amino-terminal-modified chemokine is derived from a                      
                         chemokine selected from the group consisting of SDF-lI, SDF-1J,                      
                         IP-10, Mig, GROI, GROJ, GROK, interleukin-8, PF4, ENA-78, GCP-2,                     
                         PBP, CTAP-III, J-thromboglobulin, NAP-2, C10, DC-CKI, CKIl, CKI2,                    
                         MCP-1, MCP-2, MCP-3, MCP-4, MIP-lI, MIP-1J, lymphotactin, ATAC,                      
                         eotaxin, eotaxin-2, I-309, HCC-1, HCC-2, HCC3, LARC/MIP-3I,                          
                         MIP-3J, PARC, TARC, 6Ckine, ELC, SLC, CKJ4, CKJ6, CKJ7, CKJ8,                        
                         CKJ9, CKJ11, CKJ12, CKJ13, and CX3C.                                                 
                   6.    The composition of claim 1 wherein the polynucleotide is selected from               
                         the group consisting of:                                                             
                         (a)   a polynucleotide comprising the nucleotide sequence of SEQ ID                  
                               NO: 6;                                                                         
                         (b)   a polynucleotide comprising the nucleotide sequence of the                     
                               protein-coding sequence of the polynucleotide encoding met-                    
                               hDSF-1I deposited under accession number ATCC 98506;                           
                         (c)   a polynucleotide encoding an amino-terminal-modified                           
                               chemokine comprising the amino acid sequence of SEQ ID NO:                     
                               10;                                                                            
                         (d)   a polynucleotide encoding a protein comprising an amino-                       
                               terminal fragment of the amino acid sequence of SEQ ID NO: 10;                 
                         (e)   a polynucleotide comprising a nucleotide sequence                              
                               complementary to any one of the polynucleotides specified in (a)-              
                               (d) above; and                                                                 
                         (f)   a polynucleotide capable of hybridizing at either (i) 4xSSC at                 
                               65°C or (ii) 50% formamide  and 4XSSC at 42°C, to any one of                   
                               the polynucleotides specified in (a)-(e) above.                                
                      The examiner relies on the following reference:                                         
                Proudfoot et al. (Proudfoot), ”Extension of Recombinant Human RANTES by the                   
                Retention of the Initiating Methionine Produces a Potent Antagonist,” J. Bio.                 
                Chem., Vol. 271 No. 5, pp.2599-2603 (1996)                                                    






Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007